Central Pacific Bank Trust Division Purchases 14,825 Shares of iShares Biotechnology ETF $IBB

Central Pacific Bank Trust Division boosted its position in iShares Biotechnology ETF (NASDAQ:IBB) by 296,500.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,830 shares of the financial services provider’s stock after buying an additional 14,825 shares during the quarter. Central Pacific Bank Trust Division’s holdings in iShares Biotechnology ETF were worth $2,503,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of IBB. Darwin Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the second quarter valued at about $25,000. Ashton Thomas Securities LLC acquired a new stake in shares of iShares Biotechnology ETF in the third quarter valued at about $36,000. Parkside Financial Bank & Trust increased its stake in shares of iShares Biotechnology ETF by 48.6% in the third quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock worth $38,000 after purchasing an additional 87 shares during the period. Close Asset Management Ltd increased its stake in shares of iShares Biotechnology ETF by 25.5% in the third quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock worth $50,000 after purchasing an additional 70 shares during the period. Finally, Founders Financial Alliance LLC lifted its position in shares of iShares Biotechnology ETF by 605.7% during the 3rd quarter. Founders Financial Alliance LLC now owns 374 shares of the financial services provider’s stock worth $54,000 after purchasing an additional 321 shares during the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $161.65 on Friday. The business has a 50 day moving average price of $171.97 and a 200 day moving average price of $163.30. iShares Biotechnology ETF has a twelve month low of $107.43 and a twelve month high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were issued a dividend of $0.1218 per share. The ex-dividend date was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a dividend yield of 0.3%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.